Literature DB >> 17855350

Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility.

John R Basile1, Julie Gavard, J Silvio Gutkind.   

Abstract

The semaphorins are a family of proteins originally identified as axon-guiding molecules in the developing nervous system that have been recently shown to regulate many cellular functions, including motility, in a variety of cell types. We have previously shown that in endothelial cells Semaphorin 4D acts through its receptor, Plexin-B1, to elicit a pro-angiogenic phenotype that involves the activation of the phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway. Here we show through the use of a receptor chimeric approach, Plexin-B1 mutants, and dominant negative and pharmacological inhibitors that this response is dependent upon the activation of RhoA and its downstream target, Rho kinase (ROK). Indeed, we demonstrate that in endothelial cells, Semaphorin 4D promotes the formation of focal adhesion complexes, stress fibers, and the phosphorylation of myosin light chain, a response that was abolished by the use of ROK inhibitors and absent from cells expressing Plexin-B1 mutant constructs incapable of signaling to RhoA. Stress fiber polymerization and contraction are in turn necessary for RhoA-dependent pro-angiogenic signaling through Plexin-B1. Furthermore, we observed that in endothelial cells Plexin-B1 promotes the integrin-mediated activation of Pyk2, resulting in the stimulation of PI3K, Akt, and ERK. These findings provide evidence that Plexin-B1 promotes endothelial cell motility through RhoA and ROK by regulating the integrin-dependent signaling networks that result in the activation of PI3K and Akt.

Mesh:

Substances:

Year:  2007        PMID: 17855350     DOI: 10.1074/jbc.M705467200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function.

Authors:  Paul E Clavijo; Jay Friedman; Yvette Robbins; Ellen C Moore; Ernest Smith; Maurice Zauderer; Elizabeth E Evans; Clint T Allen
Journal:  Cancer Immunol Res       Date:  2018-12-04       Impact factor: 11.151

Review 2.  Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.

Authors:  Atsuko Sakurai; Colleen L Doçi; Colleen Doci; J Silvio Gutkind
Journal:  Cell Res       Date:  2011-12-13       Impact factor: 25.617

Review 3.  Semaphorins in angiogenesis and tumor progression.

Authors:  Gera Neufeld; Adi D Sabag; Noa Rabinovicz; Ofra Kessler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 4.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

Review 5.  Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive.

Authors:  Mélanie Franco; Luca Tamagnone
Journal:  EMBO Rep       Date:  2008-07-25       Impact factor: 8.807

6.  Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury.

Authors:  Barbara Wegiel; David J Gallo; Kathleen G Raman; Jenny M Karlsson; Brett Ozanich; Beek Y Chin; Edith Tzeng; Shakil Ahmad; Asif Ahmed; Catherine J Baty; Leo E Otterbein
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

7.  Regulation of Rela/p65 and endothelial cell inflammation by proline-rich tyrosine kinase 2.

Authors:  Kaiser M Bijli; Fabeha Fazal; Arshad Rahman
Journal:  Am J Respir Cell Mol Biol       Date:  2012-07-27       Impact factor: 6.914

8.  The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal γδ T cell function.

Authors:  Deborah A Witherden; Megumi Watanabe; Olivia Garijo; Stephanie E Rieder; Gor Sarkisyan; Shane J F Cronin; Petra Verdino; Ian A Wilson; Atsushi Kumanogoh; Hitoshi Kikutani; Luc Teyton; Wolfgang H Fischer; Wendy L Havran
Journal:  Immunity       Date:  2012-08-16       Impact factor: 31.745

9.  The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1.

Authors:  Robert J Cain; Bart Vanhaesebroeck; Anne J Ridley
Journal:  J Cell Biol       Date:  2010-03-22       Impact factor: 10.539

Review 10.  Roles of Sema4D and Plexin-B1 in tumor progression.

Authors:  Ewe Seng Ch'ng; Atsushi Kumanogoh
Journal:  Mol Cancer       Date:  2010-09-21       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.